– The funding will also accelerate the commercialization of Symcel’s R&D product offering (STOCKHOLM) Symcel — a company providing real-time metabolic measurements of living organisms with their analytical instrument the calScreener™ ̶ today...
– New antibiotic potentiating activity has been discovered for treatment of Cystic Fibrosis associate infections. (STOCKHOLM) Symcel— a company providing real-time metabolic measurements for bacteria and cell culture with their product the...
– A new screening method will help to discover drugs that force the body to burn fat reserves. (STOCKHOLM) Symcel— a company providing real-time metabolic measurements for cell culture with their product the calScreener™ ̶ was recently involved in a...
– Metabolic readouts highlighted which treatment parameters were most effective. (STOCKHOLM) Symcel— a company providing real-time metabolic measurements for cell culture with their product the calScreener™ ̶ was recently involved in a publication...
(STOCKHOLM) Symcel— a company providing real-time metabolic measurements for cell culture with their product calScreener™ ̶ was recently featured in a peer-reviewed publication showing how metabolic data shed new light on the evolution of...
– New data suggest old antibiotics used in new combinations can be effective against drug resistant infections. (STOCKHOLM) Symcel— a company providing real-time metabolic measurements for cell culture with their product calScreener™ ̶ was recently...
We find ourselves in the middle of a global pandemic that is causing a great deal of uncertainty from international governments to individual families. With that in mind, I want Symcel’s position to be clear throughout and we will be posting regular...
COVID-19 is forcing everyone to reconsider how they work. At Symcel, while we place a lot of value on personal interactions, we also have strong digital workflows that allow us to do our jobs remotely. These workflows have prepared us for the...
The first publication from Symcel’s European H2020 project was published at the end of January. The project named BADGER (Bacterial Analysis and Diagnostics through Growth and Energy-release in Real-time) focuses on clinical validation for new...
The Bjarnsholt lab at the Costerton Biofilm Center finalized the purchase of a calScreener™ as part of a Novo Nordisk Fonden Tandem grant to study atopic dermatitis.